2009, Number 1
<< Back Next >>
Residente 2009; 4 (1)
Displasias óseas
Piana RA
Language: Spanish
References: 10
Page: 5-9
PDF size: 99.18 Kb.
ABSTRACT
Skeletal dysplasias are pathologies that present a generalized alteration of bone tissue and constitute one of the first causes of growth retard. Until recent times, the precise diagnosis of a skeletal dysplasia was only perinatal through clinics, biochemistry and radiology. The upcoming of Molecular Biology techniques has allowed the prenatal diagnosis of many of them allowing the adoption of measures and the correspondent genetic counseling. Some skeletal dysplasias are so severe that can be detected by ultrasound before birth. There are hundreds of skeletal dysplasias, many of them rare. Acondroplasy is the most common of them. Due to the prognosis and genetic implications, it is important that the primary physician, genetist and radiologist work together as an interdisciplinary team. There is few experience in the medical treatment for skeletal dysplasias without long term results.
REFERENCES
Ascurra M, Herreros M, Rodríguez S. Displasias óseas: a propósito de cuatro nosologías diferentes. Instituto de Investigaciones en Ciencias de la Salud 2005; 5: 98-100.
Baltaxe E, Suárez F, Garante I. Displasia campomélica. Descripción de un caso. Colombia Médica 2005; 36: 266-270.
Duchatelet S, Ostergaard E, Cortés D. Lemainique A, Julier C. Recessive mutations in PTHR1 cause contrastin skeletal dysplasias in Eiken and Blomstrand syndromes. Human Molecular Genetics 2005; 14: 1-5.
Nishimura G, Nakashima E, Mabuchi A, Shimamoto T, Shimao Y, Nagai T, Yamaguchi T, Kosaki R, Ohashi H, Makita Y, Ikewaga S. Identification of COLA2A1 mutations an platyspondylic skeletal dysplasia, Torrence type. Journal of Medical Genetics 2004; 41: 75-79.
Brooh C, de Vries B. Skeletal dysplasias. Archives of Disease in Children 1998; 79: 285-289.
Webster M, Davis P, Robertson S, Donoghue D. Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for lethal skeletal dysplasia, thanatophoric dysplasia type 2. Molecular and Cellular Biology 1996; 16: 4081-4087.
Mortier G, Kramer P, Giedon A, Beemer F. Acrocapitofemoral dysplasia: an autosomal recessive skeletal dysplasia with cone shaped epiphysis in the hands and hips. Journal of Medical Genetics 2003; 40: 201-207.
Ahuja S, Karande S, Kulkarni M. Skeletal dysplasia with inusual visceral malformations. British Medical Journal 2001; 5: 69-70.
Chan Y, Li C, Chu W, Cheng J, Chik K. Deferoxamine-induced bone dysplasia in the distal femur and patella of pediatric patients and young adults. AJR 2000; 175: 1561-1566.
Garjian K, Pretorius D, Budorick N, Cantrell C, Johnson D, Nelson T. Fetal skeletal dysplasia: three-dimensional US initial experience. Radiology 2000; 214: 717-723.